
Charvi Kalal
PharmD
Charvi Kalal is a Pharm.D intern and aspiring medical writer with hands-on experience in medical writing, clinical research, pharmacovigilance, and clinical pharmacy. She has experience in medical content writing through CliMed, along with exposure to ADR monitoring, prescription analysis, patient counselling, literature review, and research documentation. Her research focuses on ADR monitoring and reporting in breast cancer patients receiving targeted therapy. With certifications in GCP, biomedical research, scientific writing, and clinical research, she is passionate about transforming scientific evidence into accurate, engaging, and accessible healthcare content.
About Charvi
Charvi Kalal (PharmD) is a writer at Pharmacally, with 44 published articles, each checked against primary sources by our editorial team.
Articles by Charvi Kalal
Clinical TrialsLynk Reports Positive 76-Week Zemprocitinib Results in Rheumatoid Arthritis
Health TidingsInsilico’s AI-Designed ISM6331 Shows Tumor Shrinkage in Mesothelioma
Clinical TrialsAgenus Reports 72% Complete Response with BOT+BAL in dMMR Colon Cancer
Health TidingsVertex’s Povetacicept Lowers Proteinuria, FDA Decision Nears
Clinical TrialsAlnylam’s Brezosiran Delivers Up to 64% Mean Huntingtin Reduction
Clinical TrialsTG Reports 7-Year BRIUMVI Outcomes and Positive ENHANCE Results
Clinical TrialsLumen’s LMN-201 Shows Positive RePreve Results in C. difficile
Clinical TrialsIDEAYA Reports Three-Trial Progress for Darovasertib in Uveal Melanoma
Clinical TrialsKrystal’s KB113 Shows 83% BCC Regression in Gorlin Syndrome
A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala